Jushi Holdings (JUSHF) EPS (Weighted Average and Diluted) (2021 - 2026)
Jushi Holdings (JUSHF) reported EPS (Weighted Average and Diluted) of -$0.1 for Q1 2026, down 11.11% year-over-year from -$0.11 in Q1 2025, and down 25.0% quarter-over-quarter from -$0.08 in Q4 2025.
Jushi Holdings (JUSHF) EPS (Weighted Average and Diluted) (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of EPS (Weighted Average and Diluted) data on file, last reported at -$0.1 in Q1 2026.
- EPS (Weighted Average and Diluted) for Q1 2026 came in at -$0.1, down 11.11% year-over-year; the trailing twelve-month figure through Mar 2026 was -$0.36 (down 50.0% YoY), and the FY2025 annual result was -$0.35, down 40.0% from the prior year.
- EPS (Weighted Average and Diluted) slipped to -$0.1 in Q1 2026 per JUSHF's latest filing, from -$0.08 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at -$0.01 in Q2 2024 and troughed at -$0.83 in Q4 2022.
- A 5-year average of -$0.14 and a median of -$0.09 in 2024 frame the typical range for EPS (Weighted Average and Diluted).
- The sharpest annual moves came in 2023 and 2025: EPS (Weighted Average and Diluted) surged 89.16% in 2023, then sank 500.0% in 2025.
- A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.83 in 2022, then surged by 89.16% to -$0.09 in 2023, then surged by 33.33% to -$0.06 in 2024, then plunged by 33.33% to -$0.08 in 2025, then dropped by 25.0% to -$0.1 in 2026.
- Business Quant data shows JUSHF's EPS (Weighted Average and Diluted) at -$0.1 in Q1 2026, -$0.08 in Q4 2025, and -$0.12 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Weighted Avg. Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 0.31 |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 1.42 |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 5.82 |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 0.02 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 1.91 |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 0.11 |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -0.40 |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -0.40 |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.80 |
| 10 | Jushi Holdings | - | - | 29.88 Mn | -0.10 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.10 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | -0.12 |
| Jun 30, 2025 | -0.06 |
| Mar 31, 2025 | -0.09 |
| Dec 31, 2024 | -0.06 |
| Sep 30, 2024 | -0.08 |
| Jun 30, 2024 | -0.01 |
| Mar 31, 2024 | -0.09 |
| Dec 31, 2023 | -0.09 |
| Sep 30, 2023 | -0.11 |
| Jun 30, 2023 | -0.07 |
| Mar 31, 2023 | -0.06 |
| Dec 31, 2022 | -0.83 |
| Sep 30, 2022 | -0.30 |
| Jun 30, 2022 | -0.15 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | -0.14 |
| Sep 30, 2021 | -0.08 |
| Jun 30, 2021 | -0.09 |